These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 12616452

  • 1. Treatment of HBe antigen-positive chronic hepatitis B.
    Heathcote J.
    Semin Liver Dis; 2003 Feb; 23(1):69-80. PubMed ID: 12616452
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Beneficial effects of 'lamivudine pulse' therapy in HBeAg-positive patients with normal ALT*.
    Sarin SK, Sandhu BS, Sharma BC, Jain M, Singh J, Malhotra V.
    J Viral Hepat; 2004 Nov; 11(6):552-8. PubMed ID: 15500556
    [Abstract] [Full Text] [Related]

  • 4. [Efficacy and safety in chronic hepatitis B adolescent patients with lamivudine therapy].
    Lu WL, Xie DY, Yao JL, Yao GB, Cui ZY, Zhang DF, Wu L.
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):429-31. PubMed ID: 15268810
    [Abstract] [Full Text] [Related]

  • 5. Long-term follow-up of lamivudine treatment in patients with severe acute exacerbation of hepatitis B e antigen (HBeAg)-positive chronic hepatitis B.
    Wong VW, Wong GL, Tsang SW, Hui AY, Chim AM, Yiu KK, Chan HY, Chan FK, Sung JJ, Chan HL.
    Antivir Ther; 2008 Jul; 13(4):571-9. PubMed ID: 18672536
    [Abstract] [Full Text] [Related]

  • 6. Effectiveness of lamivudine and interferon-alpha combination therapy versus interferon-alpha monotherapy for the treatment of HBeAg-negative chronic hepatitis B patients: a randomized clinical trial.
    Karabay O, Tamer A, Tahtaci M, Vardi S, Celebi H.
    J Microbiol Immunol Infect; 2005 Aug; 38(4):262-6. PubMed ID: 16118673
    [Abstract] [Full Text] [Related]

  • 7. Long-term lamivudine monotherapy in renal-transplant recipients with hepatitis-B-related cirrhosis.
    Viganò M, Colombo M, Aroldi A, Lunghi G, Manenti E, Ponticelli C, Lampertico P.
    Antivir Ther; 2005 Aug; 10(6):709-13. PubMed ID: 16218169
    [Abstract] [Full Text] [Related]

  • 8. Interferon-lamivudine combination is no better than lamivudine alone in anti-HBe-positive chronic hepatitis B.
    Akarca US, Ersoz G, Gunsar F, Karasu Z, Saritas E, Yuce G, Batur Y.
    Antivir Ther; 2004 Jun; 9(3):325-34. PubMed ID: 15259895
    [Abstract] [Full Text] [Related]

  • 9. [Chronic hepatitis B. Recent advances in diagnosis and treatment].
    Bernardi M, Biselli M, Gramenzi A.
    Recenti Prog Med; 2002 Jun; 93(7-8):397-402. PubMed ID: 12138683
    [Abstract] [Full Text] [Related]

  • 10. A higher alanine aminotransferase level correlates with earlier hepatitis B e antigen seroconversion in lamivudine-treated chronic hepatitis B patients.
    Tseng TC, Liu CJ, Wang CC, Chen PJ, Lai MY, Kao JH, Chen DS.
    Liver Int; 2008 Aug; 28(7):1034-41. PubMed ID: 18492018
    [Abstract] [Full Text] [Related]

  • 11. Combination of pegylated interferon and lamivudine for patients with chronic hepatitis B who have failed treatment.
    Sarin SK, Kumar M, Hissar S, Sharma BC.
    Hepatobiliary Pancreat Dis Int; 2006 Aug; 5(3):374-80. PubMed ID: 16911934
    [Abstract] [Full Text] [Related]

  • 12. Entecavir therapy for up to 96 weeks in patients with HBeAg-positive chronic hepatitis B.
    Gish RG, Lok AS, Chang TT, de Man RA, Gadano A, Sollano J, Han KH, Chao YC, Lee SD, Harris M, Yang J, Colonno R, Brett-Smith H.
    Gastroenterology; 2007 Nov; 133(5):1437-44. PubMed ID: 17983800
    [Abstract] [Full Text] [Related]

  • 13. Effect of long-term lamivudine in chronic hepatitis B virus-infected children.
    Ozgenç F, Arikan C, Sertoz RY, Nart D, Aydogdu S, Yagci RV.
    Antivir Ther; 2004 Oct; 9(5):729-32. PubMed ID: 15535410
    [Abstract] [Full Text] [Related]

  • 14. Comparison of interferon and lamivudine treatment in Japanese patients with HBeAg positive chronic hepatitis B.
    Arase Y, Ikeda K, Suzuki F, Suzuki Y, Kobayashi M, Akuta N, Hosaka T, Sezaki H, Yatsuji H, Kawamura Y, Kobayashi M, Kumada H.
    J Med Virol; 2007 Sep; 79(9):1286-92. PubMed ID: 17607775
    [Abstract] [Full Text] [Related]

  • 15. [Therapy effect of lamivudine combination with alpha interferon on patients with chronic hepatitis B].
    Deng H, Zhao ZX, Xu QH, Zhou YP, Chen YM, Yao JL.
    Zhonghua Gan Zang Bing Za Zhi; 2003 May; 11(5):305-8. PubMed ID: 12773249
    [Abstract] [Full Text] [Related]

  • 16. An extended two-year trial of lamivudine in Chinese patients with chronic hepatitis B.
    Yao G, Cui Z, Wang B, Yao J, Zeng M.
    Chin Med J (Engl); 2002 Dec; 115(12):1814-8. PubMed ID: 12622930
    [Abstract] [Full Text] [Related]

  • 17. Treatment of chronic hepatitis B: interferon alfa first.
    Prescrire Int; 2001 Feb; 10(51):17-21. PubMed ID: 11503853
    [Abstract] [Full Text] [Related]

  • 18. Durability of serologic response after lamivudine treatment of chronic hepatitis B.
    Dienstag JL, Cianciara J, Karayalcin S, Kowdley KV, Willems B, Plisek S, Woessner M, Gardner S, Schiff E.
    Hepatology; 2003 Apr; 37(4):748-55. PubMed ID: 12668966
    [Abstract] [Full Text] [Related]

  • 19. Two-year lamivudine treatment for hepatitis B e antigen-negative chronic hepatitis B: a double-blind, placebo-controlled trial.
    Chan HL, Wang H, Niu J, Chim AM, Sung JJ.
    Antivir Ther; 2007 Apr; 12(3):345-53. PubMed ID: 17591024
    [Abstract] [Full Text] [Related]

  • 20. A 7-year study of lamivudine therapy for hepatitis B virus e antigen-positive chronic hepatitis B patients in China.
    Yao GB, Zhu M, Cui ZY, Wang BE, Yao JL, Zeng MD.
    J Dig Dis; 2009 May; 10(2):131-7. PubMed ID: 19426396
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.